PURPOSE: We determined the prognostic value of self-reported and performance-based measurement of function, including functional transitions and combining different measurement approaches, on utilization. DESIGN AND METHODS: Our cohort study used the 6th, 7th, and 10th waves of three sites of the Established Populations for Epidemiologic Studies of the Elderly, linked to 1- and 4-year Medicare Part A hospital costs. We examined mean hospital expenditures based on (a) 1- and 4-year transitions in self-reported functional status; (b) 4-year transitions in performance-based functional status; (c) combined baseline self-reported and performance-based functional status; and (d) poorest self-reported and performance-based functional status during a 4-year period. RESULTS: Even modest declines in self-reported or performance-based functional status were associated with increased expenditures. When baseline self-reported and performance-based assessments were combined, mean 1- and 4-year adjusted costs were higher with progressively worse performance-based scores, even among those who were independent in self-reported function. When the poorest 4-year self-reported and performance-based functions were examined, self-reported functioning was the most important determinant of hospital costs, but within each self-reported functional level, poorer performance-based function was associated with progressively higher costs. IMPLICATIONS: The costs associated with even modest functional decline are high. Combining self-reported and performance-based measurements can provide more precise estimates of future hospital costs. Copyright 2004 The Gerontological Society of America
PURPOSE: We determined the prognostic value of self-reported and performance-based measurement of function, including functional transitions and combining different measurement approaches, on utilization. DESIGN AND METHODS: Our cohort study used the 6th, 7th, and 10th waves of three sites of the Established Populations for Epidemiologic Studies of the Elderly, linked to 1- and 4-year Medicare Part A hospital costs. We examined mean hospital expenditures based on (a) 1- and 4-year transitions in self-reported functional status; (b) 4-year transitions in performance-based functional status; (c) combined baseline self-reported and performance-based functional status; and (d) poorest self-reported and performance-based functional status during a 4-year period. RESULTS: Even modest declines in self-reported or performance-based functional status were associated with increased expenditures. When baseline self-reported and performance-based assessments were combined, mean 1- and 4-year adjusted costs were higher with progressively worse performance-based scores, even among those who were independent in self-reported function. When the poorest 4-year self-reported and performance-based functions were examined, self-reported functioning was the most important determinant of hospital costs, but within each self-reported functional level, poorer performance-based function was associated with progressively higher costs. IMPLICATIONS: The costs associated with even modest functional decline are high. Combining self-reported and performance-based measurements can provide more precise estimates of future hospital costs. Copyright 2004 The Gerontological Society of America
Authors: Cynthia Owusu; Mark Schluchter; Siran M Koroukian; Suzanne Mazhuvanchery; Nathan A Berger Journal: Cancer Date: 2013-09-23 Impact factor: 6.860
Authors: Emmett Keeler; Jack M Guralnik; Haijun Tian; Robert B Wallace; David B Reuben Journal: J Gerontol A Biol Sci Med Sci Date: 2010-04-02 Impact factor: 6.053
Authors: Cynthia Owusu; Seunghee Margevicius; Mark Schluchter; Siran M Koroukian; Kathryn H Schmitz; Nathan A Berger Journal: Cancer Date: 2016-06-27 Impact factor: 6.860
Authors: Cynthia Owusu; Nora L Nock; Paul Hergenroeder; Kristina Austin; Elizabeth Bennet; Stephen Cerne; Halle Moore; Jean Petkac; Mark Schluchter; Kathryn H Schmitz; Monica Webb Hooper; Lindsay Atkins; Oghenerukeme Asagba; Leonard Wimbley; Nathan A Berger Journal: Contemp Clin Trials Date: 2020-04-15 Impact factor: 2.226